Pulmicort Asthma Prevention (Post-PAC)
A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)
A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)
Sponsor study identifier
interventional
400
1 country
1
Study Start
July 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2006
Actual (reported)Study Completion
June 2006
Actual (reported)This prospective study will evaluate the feasibility of the defined decision tree for the treatment of asthmatic young children. Children who develop episode (=3 consecutive days) of any troublesome lower respiratory symptoms are treated according to a strictly pre-defined multi-steps treatment algorithm until the age of 6 years.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2001
Date type not reportedThis date has not been verified as actual or estimated.
October 4, 2005
Actual (reported)October 6, 2005
Actual (reported)May 2006
Actual (reported)June 2006
Actual (reported)Success rate of the treatment algorithm: Frequency of protocol deviations, asthma exacerbations, different treatment steps.
Efficacy - development of lung function.
Acceptability of the treatment algorithm by the parents.
Growth rate and BMD.
Exhaled nitrogen Oxide, bronchohyperresponsiveness.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Research Site
Copenhagen, Denmark
AstraZeneca Denmark Medical Director, MD
AstraZeneca
First Submitted
October 4, 2005
First Posted
October 6, 2005
Study Start
July 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2006
Actual (reported)Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
Contact the study team to confirm eligibility.
Study Completion
June 2006
Actual (reported)Last Updated
January 14, 2008
Record last verified: 2008-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: